HEIDELBERG evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage: FULL_STATEMENTS
Financial source retrieved: 2026-09-10T14:01:40.798557+00:00

Metrics

latest_annual_period: 2026-03-31
revenue: 23295900000.0
net_income: 1339700000.0
operating_cash_flow: 2128600000.0
free_cash_flow: 1604800000.0
total_assets: 24382500000.0
total_liabilities: 10664000000.0
total_equity: 13718500000.0
cash: 4078400000.0
total_debt: 142300000.0
revenue_growth: 0.08409497040318681
earnings_growth: 0.2549882903981264
net_margin: 0.057507973506067595
roe: 0.09765644932026096
debt_to_equity: 0.010372854175019135
cash_conversion: 1.5888631783235052
free_cash_flow_margin: 0.06888765834331363
trailing_pe: 23.52
forward_pe: Not supplied
peg_ratio: Not supplied
price_to_book: Not supplied
dividend_yield: Not supplied

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

No active, unexpired validation authority for this exact strategy and horizon.
A source-backed entry, invalidation, exit and cost plan is not supplied.

Eligible expression: None selected
Expression comparison: No eligible instrument selected.

Invalidation: Continued price deterioration or adverse fundamental evidence
Entry rule: Not supplied
Entry range (INR): Not supplied
Exit / review rule: Not supplied
Planned exit: Not supplied
Plan valid until: Not supplied
Promotion reference: Not supplied

Instrument scenarios in INR; quantities are illustrative, not personal sizing
Instrument	Evidence status	Contract	Quantity	Capital / margin	Target P&L after costs	Stop-level scenario P&L	Stress loss	Conditions and limitations
NO_POSITION	Available	Not supplied	Not supplied	Not supplied	0.00	0.00	Not supplied	No new position; incremental trading P&L is zero.
CASH	Unavailable	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Observed contract, quote and cost evidence not supplied.
FUTURES	Unavailable	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Observed contract, quote and cost evidence not supplied.
OPTIONS	Unavailable	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Not supplied	Observed contract, quote and cost evidence not supplied.

No reader capital or loss budget supplied

Decision provenance and limitations

Decision ID: decision-8a23103aacc925357ae364b3be8095eafdd61758ff87acbcde407172448eee55
Policy: stock-decisions-v1
Evidence bundle hash: 04b86c0278793603e067fb5c48c046aa962ac5db0b2708bad6deef235d82aa5e

market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
financial-statements: 20819dcaee2307d9e06af1b9be267fb798a76c13d7818f942c08381428b23126
daily-price: 6e65a746ac80a8052a474136cec955a3d4874c7a2902e65f089ce4f22ceb272f

Conditional research decisions are not orders or personalized position sizes.
Scenario payoffs are assumptions, not probabilities or expected returns.
A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 250-session price return was -34.37%. The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.08409497040318681.

Risks

The trailing 60-session price return was -14.10%. The closing price was -34.37% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Average cached traded value over twenty sessions was INR 33,758,432. The cached financial metric roe is 0.09765644932026096. The cached financial metric debt to equity is 0.010372854175019135.

Cached observations and evidence limits

Price source verification: REPAIRED.
The cached closing price on 2026-10-01 was INR 130.57.
The trailing 5-session price return was -6.39%.
The trailing 20-session price return was -13.48%.
The trailing 60-session price return was -14.10%.
The trailing 250-session price return was -34.37%.
Average cached traded value over twenty sessions was INR 33,758,432.
The closing price was -34.37% below its highest close in the available trailing year.
Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-10T14:01:40.798557+00:00 from EODHD.
The cached financial metric latest annual period is 2026-03-31.
The cached financial metric revenue growth is 0.08409497040318681.
The cached financial metric net margin is 0.057507973506067595.
The cached financial metric roe is 0.09765644932026096.
The cached financial metric debt to equity is 0.010372854175019135.
The cached financial metric cash conversion is 1.5888631783235052.
The cached financial metric free cash flow margin is 0.06888765834331363.
Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.